CID is 3478
synonyms found at PubChem are:
glipizide, 29094-61-9, Glucotrol, Glydiazinamide, Melizide, Glibenese, Glucozide, Glupizide, Sucrazide, Dipazide, Glupitel, Mindiab, Minidiab, Minodiab, Napizide, Ozidia, Glucotrol XL, Glibetin, Glucolip, Aldiab, Digrin, Glican, Glidiab, Glipid, Minidab, Glyde, Gluco-Rite, Glipizidum, Glipizida, Glide, Glidiazinamide, Glypidizine, Metaglip, Glipizidum [INN-Latin], Glipizida [INN-Spanish], K 4024, K-4024, CP 28720, Semiglynase, TK 1320, C21H27N5O4S, CP-28720, CP 28,720, UNII-X7WDT95N5C, Glucotrol (TN), Glipizide [USAN:BAN:INN], Glipizide (Glucotrol), Glipizide (USP/INN), EINECS 249-427-6, BRN 0903495, CHEMBL1073, X7WDT95N5C, 1-Cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)urea, MLS000069386, N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-5-methylpyrazine-2-carboxamide, CHEBI:5384, K4024, Glipizide Extended-Release Tablets, N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-5-methylpyrazine-2-carboxamide, N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-5-methylpyrazine-2-carboxamide, N-(4-(beta-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea, Pyrazinecarboxamide, N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-5-methyl-, KS-1068, NCGC00015462-07, SMR000058455, CP-28,720, CAS-29094-61-9, G-117, 1-cyclohexyl-3-[[p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl]sulfonyl]urea, DSSTox_CID_20676, DSSTox_RID_79535, Urea, 1-cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)-, DSSTox_GSID_40676, W-107005, 1-cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea, 1-Cyclohexyl-3-{4-[2-(5-methylpyrazine-2-carboxamido)ethyl]phenylsulfonyl}urea, N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazine-2-carboxamide, N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide, N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-N'-cyclohexylurea, 29094-66-4, Pyrazinecarboxamide, N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methyl-, SR-01000000010, glipizid, Glipizibe, Glipizide, solid, N-(4-[N-(cyclohexylcarbamoyl)sulfamoyl]phenethyl)-5-methylpyrazine-2-carboxamide, Glipizide [USAN:USP:INN:BAN], Glipizide,(S), Prestwick_242, Metaglip (Salt/Mix), Glipizide Kenfarma Brand, Lopac-G-117, Lacer Brand of Glipizide, Lilly Brand of Glipizide, Opera_ID_1908, Prestwick0_000131, Prestwick1_000131, Prestwick2_000131, Prestwick3_000131, D0Z4SB, Samarium(III) ionophore I, AC1L1G0Z, AC1Q2OG0, Kenfarma Brand of Glipizide, PfizerBrand 1 of Glipizide, Glibenese Brand of Glipizide, CBiol_001788, Lopac0_000621, SCHEMBL17094, BSPBio_000202, BSPBio_001349, KBioGR_000069, KBioSS_000069, Pfizer Brand 2 of Glipizide, Alphapharm Brand of Glipizide, MLS001148176, BIDD:GT0476, SPBio_002141, BPBio1_000224, GTPL6821, DTXSID0040676, CTK8B3212, KBio2_000069, KBio2_002637, KBio2_005205, KBio3_000137, KBio3_000138, MolPort-002-885-830, ZJJXGWJIGJFDTL-UHFFFAOYSA-N, Bio1_000074, Bio1_000563, Bio1_001052, Bio2_000069, Bio2_000549, HMS1361D11, HMS1568K04, HMS1791D11, HMS1989D11, HMS2089C21, HMS2093J09, HMS2095K04, HMS2233N11, HMS3259K12, HMS3261N04, HMS3369L12, HMS3402D11, HMS3655G04, HMS3712K04, Pharmakon1600-01505433, ZINC537795, BCP09195, Glucotrol XL, Glucotrol, Glipizide, HY-B0254, Tox21_110156, Tox21_301834, Tox21_500621, ANW-41980, BBL028143, BDBM50012956, BG0209, MFCD00072159, NSC759120, s1715, STK631952, AKOS005564405, Tox21_110156_1, API0002842, CCG-204710, CS-2239, DB01067, LP00621, MCULE-5142805548, NC00564, NSC-759120, IDI1_033819, NCGC00015462-01, NCGC00015462-02, NCGC00015462-03, NCGC00015462-04, NCGC00015462-05, NCGC00015462-06, NCGC00015462-08, NCGC00015462-09, NCGC00015462-10, NCGC00015462-11, NCGC00015462-12, NCGC00015462-14, NCGC00016802-01, NCGC00023748-03, NCGC00023748-04, NCGC00023748-05, NCGC00023748-06, NCGC00023748-07, NCGC00255522-01, NCGC00261306-01, AC-15789, AN-15826, BC209538, CC-28982, CPD000058455, KB-52251, SAM002564210, SC-13933, SBI-0050603.P002, AB0012143, LS-159679, TC-063559, TL8006447, EU-0100621, FT-0626714, FT-0659737, G0369, ST50826363, D00335, 094G619, C-22417, I06-0186, I06-1985, SR-01000000010-2, SR-01000000010-5, BRD-K12219985-001-04-8, BRD-K12219985-001-15-4, Z1880962274, Glipizide, European Pharmacopoeia (EP) Reference Standard, Glipizide, United States Pharmacopeia (USP) Reference Standard, Glipizide, Pharmaceutical Secondary Standard; Certified Reference Material, N-[4-(3-Cyclohexylureidosulfonyl)phenethyl]-5-methyl-2-pyrazinecarboxamide, 1-cyclohexyl-3-(4-(2-(2-methylpyrazine-5-carboxamido)ethyl)phenylsulfonyl)urea, N-(4-(.beta.-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea, 172964-66-8, 38777-27-4, N-(2-[4-(([(Cyclohexylamino)carbonyl]amino)sulfonyl)phenyl]ethyl)-5-methyl-2-pyrazinecarboxamide, N-[2-(4-{[(cyclohexylamino)carbonylamino]sulfonyl}phenyl)ethyl](5-methylpyrazi n-2-yl)carboxamide